Chargement en cours...

Proteomics in Melanoma Biomarker Discovery: Great Potential, Many Obstacles

The present clinical staging of melanoma stratifies patients into heterogeneous groups, resulting in the application of aggressive therapies to large populations, diluting impact and increasing toxicity. To move to a new era of therapeutic decisions based on highly specific tumor profiling, the disc...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sabel, Michael S., Liu, Yashu, Lubman, David M.
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2011
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3195774/
https://ncbi.nlm.nih.gov/pubmed/22084682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/181890
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!